Oct 24, 2024 | Blog, Neurological Disorders, Stem Cell News, Stem Cell Therapies
The results reported from Phase II of the first FDA-approved trial for the treatment of multiple sclerosis (MS) using stem cells are highly promising, suggesting that stem cells could be a viable treatment option to help improve the lives of those with the condition....
Oct 17, 2024 | Blog, Stem Cell News, Stem Cell Therapies
New research has demonstrated the significant role stem cells play in skin and hair development, which could lead to revolutionary new anti-ageing treatments. [1] By identifying the ways in which the body grows skin, researchers believe that their findings could lead...
Sep 20, 2024 | Blog, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood, Uses for Cord Tissue, Uses for Placenta
Last month researchers at The Parent’s Guide to Cord Blood Foundation compiled a report about how perinatal stem cells were being employed in clinical trials from 2019 through to the end of 2023. [1] Perinatal stem cells are those which are collected in and around the...
Sep 3, 2024 | Blog, Stem Cell News, Stem Cell Therapies
Advancements in stem cell research are transforming how we could approach some of the most critical health conditions. One particularly exciting area of research is the use of umbilical cord stem cells in treating acute liver failure (ALF). ALF is a life-threatening...
Aug 21, 2024 | Blog, Heart and Vascular Disease, News, Stem Cell News, Stem Cell Therapies
A new clinical trial investigating the use of umbilical cord stem cells to treat chronic heart failure is currently underway. The Phase II trial, which is the first of its kind in the U.S., is being carried out by researchers at the University of Louisville. It’s also...
Aug 14, 2024 | Blog, Blood Disorders, News, Stem Cell News, Stem Cell Therapies
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the NHS. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and received approval from the UK...